News

Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during ...
Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during and after standard-of-care surgery had longer event-free survival without ...
Numerous studies conducted by researchers at Dana-Farber Cancer Institute report progress for cancers including head and neck cancer, metastatic breast cancer and lung cancer.
Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during ...
Dana-Farber Brigham Cancer Center-led phase 3 clinical trial shows that pembrolizumab before and after standard-of-care surgery significantly extends ...
From new cancer therapies to innovative military health care and technology, Harvard's cutting-edge projects are in jeopardy ...
Jim Higgins has an inherited cancer syndrome that has killed his father, sister, and two daughters. He fears NIH cuts will ...
Zentalis Pharmaceuticals, Inc.’s ZNTL share price has dipped by 5.96%, which has investors questioning if this is right time to buy.
Residual cancer after neoadjuvant therapy predicts recurrence years later in men undergoing surgery for high-risk prostate cancer.
A retired teacher from Austin, Texas, will run the Boston Marathon on Monday in hopes of raising awareness for brain cancer ...
Dana Perino warns this will cause 'generational harm' to the Democratic Party 'The Five' co-hosts discuss Democrats appearing to dodge accountability for denying questions about former President ...